June 14, 2011 – Accuray announced that it has completed its previously announced acquisition of TomoTherapy. The combined company is focused on developing, manufacturing and selling personalized treatment solutions that revolve around the patient.

June 14, 2011 —A study revealed at SNM’s 58th annual meeting is comparing the breast-tumor detection capabilities of two very different imaging technologies — breast-specific gamma imaging (BSGI), which provides functional images of breast physiology, and ultrasound — for women with complex breast imaging cases that require further evaluation. Many women who have dense breast tissue (radiodense breasts) are difficult to image using mammography, currently the gold standard of breast imaging. For women whose mammograms are not clear enough to determine whether cancer is present, support methods such as BSGI and ultrasound are used to answer any remaining diagnostic questions.

June 14, 2011 –FDA has given clearance to AngioViz, a GE application that gives doctors a new visualization of vascular flow on a single image to help them make important decisions during complex interventional radiology procedures.

Expanding upon its radiopharmacy platform, GE Healthcare is introducing new tracers to the FASTlab multi-tracer platform, an advanced positron emission tomography (PET) chemistry system on which the company is also developing PET proprietary agents. The system offers a number of significant enhancements to address the ever-evolving challenges of tracer production. With the addition of three new cassettes, users can access and produce FDG phosphate formulation, NaF, FMISO (HPLC free), FLT (HPLC free) and FDG citrate formulation (equivalent to TRACERlab MX standard formulation) on the same platform.

For more information: www.gehealthcare.com

A study presented at the Society of Nuclear Medicine's (SNM) annual meeting outlines a PET imaging method that reduces “motion artifacts” or image blurring arising from respiratory motion. Non-gated PET imaging with 4-D computed tomography (CT) may be useful for imaging patients who do not benefit from the use of respiratory gating, most notably patients with erratic breathing.

June 10, 2011 – The U.S. Food and Drug Administration (FDA) granted Siemens Healthcare 510(k) clearance for the Biograph mMR, the first system worldwide to enable simultaneous whole-body acquisition of data from magnetic resonance (MR) and positron emission tomography (PET).

June 10, 2011 – Viztek debuted an exam turnaround time (TAT) management feature for its Opal-RAD PACS. Designed to streamline the workflow of teleradiology practices, the feature prioritizes exams based on a client’s contracted time to perform study reading. The feature uses a color-based system to notify radiologists of the remaining time before a scheduled reading must be completed. After users input reading time parameters for each facility, worklist population and priority level is fully automatic.

June 10, 2011 – Dilon Diagnostics introduced the U.S. Food and Drug Administration (FDA)-cleared Dilon 6800 Acella gamma camera system this week at the Society of Nuclear Medicine (SNM) annual meeting in San Antonio, Texas. To complement the Dilon 6800 standard field-of-view imaging system, the new camera will feature a much larger molecular breast imaging (MBI), which will make Dilon the first company in the industry to offer customers a choice in detector sizes.

June 10, 2011 — At the Society of Nuclear Medicine’s 58th Annual Meeting in San Antonio, June 4-8, Cardinal Health previewed The Center for the Advancement of Molecular Imaging (The Center), its new, first-of-its-kind innovation laboratory, which it plans to open in July 2011.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now